Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Frequently asked questions
What sector does Endonovo Therapeutics Inc (ENDV) operate in?
Endonovo Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Endonovo Therapeutics Inc (ENDV) current stock price?
As of the latest data, Endonovo Therapeutics Inc stock price is $0.00, with a previous close of $0.00.
What is Endonovo Therapeutics Inc (ENDV) current market capitalization?
Endonovo Therapeutics Inc market cap is approximately 180.76 thousand.
What is Endonovo Therapeutics Inc (ENDV) EBITDA?
Endonovo Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -279.02 thousand.
Does Endonovo Therapeutics Inc (ENDV) pay dividends?
No. Endonovo Therapeutics Inc does not pay a dividend.
What is Endonovo Therapeutics Inc (ENDV) beta (volatility) score?
Endonovo Therapeutics Inc has a beta of 38.162, indicating very high volatility compared to the market.